Tolerability and Safety of Large-Volume Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% Administered with or Without Dose Ramp-Up: A Phase 1 Study in Healthy Participants.
JOURNAL OF CLINICAL IMMUNOLOGY（2024）
Key words
Safety,Facilitated Subcutaneous Immunoglobulin (fSCIG),Dose ramp-up
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined